Filing Details
- Accession Number:
- 0001246360-17-000853
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-02-21 16:14:17
- Reporting Period:
- 2017-02-16
- Filing Date:
- 2017-02-21
- Accepted Time:
- 2017-02-21 16:14:17
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 818479 | Dentsply Sirona Inc. | XRAY | Dental Equipment & Supplies (3843) | 391434669 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1206041 | T Christopher Clark | 221 West Philadelphia Street Suite 60W York PA 17401 | President & Ceo Technologies | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-02-16 | 55,900 | $25.91 | 55,916 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-02-16 | 55,900 | $60.34 | 16 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2017-02-17 | 8,600 | $25.91 | 8,616 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-02-17 | 8,600 | $63.05 | 16 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option | Disposition | 2017-02-16 | 55,900 | $0.00 | 55,900 | $25.91 |
| Common Stock | Stock Option | Disposition | 2017-02-17 | 8,600 | $0.00 | 8,600 | $25.91 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 55,900 | 2018-12-08 | No | 4 | M | Direct | |
| 47,300 | 2018-12-08 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 57,687 | Indirect | By Spouse |
Footnotes
- This option is fully vested and exercisable.
- This sale was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $60.06 to $60.56, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $63.00 to $63.42, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
Billionaire Hedge Funds
